23 Nov

Results of Meeting Percentages

IMUGENE LIMITED ACN 009 179 551 WWW.IMUGENE.COM info@imugene.com ASX Announcement RESULTS (percentage) OF ANNUAL GENERAL MEETING _____________ ________________ __________________________________________________________ 2 3 November 2021 Imugene Limited (ASX: IMU) presents the results percentages of Friday ’s Annual General Meeting . All resolutions were determined on a poll . Resolutions 1 and 3 were passed. Resolution 2 was not passed. In accordance with Listing Rule 3.13.2 and Section 251AA of the Corporations Act 2001, details of the resolutions and the proxies received in respect of each resolution are set out in the attached proxy summary. On behalf of the Board, Phillip Hains Company Secretary IMUGENE LIMITED ACN 009 179 551 WWW.IMUGENE.COM info@imugene.com Result Resolution # Resolution Decided by Total number of valid proxy votes * For Against Abstain * Proxy Discretion For Against Abstain Passed / Not Passed 1 Remuneration report Poll 839,263,762 785,218,114 41,152,501 211,003,104 12,893,147 1,276,140,962 41,152,501 212,362,437 Passed 100.0% 93.6% 4.9% 1.5% 96.9% 3.1% 2 Re-election of Director Dr Axel Hoos Poll 1,063,642,049 834,225,005 216,236,476 10,247,981 13,180,568 831,444,111 1,055,914,504 9,420,432 Not Passed 100.0% 78.4% 20.3% 1.2% 44.1% 55.9% 3 Ratification of previous equity issuance Poll 297,494,154 289,227,799 2,291,698 62,332,337 5,974,657 995,401,890 2,291,698 62,333,941 Passed 100.0% 97.2% 0.8% 2.0% 99.8% 0.2% In accordance with section 251AA of the Corporations Act 2001, the above information is provided in relation to resolutions put to members at the 2021 Annual General Meeting * Note: Total Number and % of Valid Proxy Votes excludes Abstain Imugene Limited 2021 AGM Results Proxy Votes Poll Results
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Imugene Limited (ASX:IMU) when you join Listcorp.